Back to Trades
Shenouda Maged
Chief Financial OfficerCIK 0001658369
Profile
- Filings
- 3
- Buy transactions
- 4
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
Shenouda Maged, Chief Financial Officer, has filed 3 SEC reports (2025–2026), all concentrated in RELMADA THERAPEUTICS, INC. (RLMD), totaling $5.4M in disclosed volume. Weighing $2.0M bought versus $0 sold, the history is heavily weighted toward buying. The largest single open-market purchase on record is $1.1M in RELMADA THERAPEUTICS, INC.. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Sep 11 | RLMD RELMADA THERAPEUTICS, INC. | Shenouda Maged | Chief Financial Officer | Buy | $844.0K |
| Dec 16 | RLMD RELMADA THERAPEUTICS, INC. | Shenouda Maged | Chief Financial Officer | Buy | $48.1K |
| Nov 6 | RLMD RELMADA THERAPEUTICS, INC. | Shenouda Maged | Chief Financial Officer | Buy | $1.1M |
3 filings